Tác động của điều trị pentosanpolysulfate qua đường niệu đạo đến triệu chứng của bệnh nhân bị hội chứng đau bàng quang/viêm bàng quang kẽ: kết quả sơ bộ

Hanno PM (2005) Painful bladder syndrome/interstitial cystitis and related disorders. In: Patrick C, Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ (eds) Campbell’s urology. 8th edn. Saunders, Philadelphia, p 631 Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735 Parsons CL, Housley T, Schmidt JD, Lebow D (1994) Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73:504–507 Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo controlled study of intravesical pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol 79:168–171 Steinhoff G, Ittah B, Rowan S (2002) The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 9:1454–1458 Riedl CR, Daha LK, Pflüger H, Hohlbrugger G (2004) Intravesical hyaluronic acid for the treatment of interstitial cystitis: an update. Eur Urol Suppl 3, Nr. 2: A LB15 Morales A, Emerson L, Nickel JC, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:145 Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26–29 Holm-Bentzen M, Jacobsen F, Nerstrøm B, Lose G, Kristensen JK, Pedersen RH, Krarup T, Feggetter J, Bates P, Barnard R, Larsen S, Hals T (1987) A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 138:503–507 Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR (1990) Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 35:552–558 Karsenty G, AlTaweel W, Hajebrahimi S, Corcos J (2006) Efficacy of interstitial cystitis treatment: a review. EAU-EBU Update Series 4:47–61 Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on interstitial cystitis. National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140:203–206 O’Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J (1997) The interstitial cystitis symptom index and problem index. Urology 49[5A Suppl]:58–63 Kallestrup EB, Steinunn S, Jørgensen S, Nordling J, Hald T (2005) Treatment of interstitial cystitis with Cystistat®: a hyaluronic acid product. Scand J Urol Nephrol 39:143–147 Stein PC, Torri A, Parsons LC (1999) Elevated urinary norepinephrine in interstitial cystitis. Urology 53:1140–1143 Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC (2000) Pentodanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol 164:2119–2125